175 related articles for article (PubMed ID: 7557245)
21. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
22. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
Kinoshita M; Saito N; Tamaki H
Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.
Natale G; Lazzeri G; Lubrano V; Colucci R; Vassalle C; Fornai M; Blandizzi C; Del Tacca M
Toxicol Appl Pharmacol; 2004 Feb; 195(1):62-72. PubMed ID: 14962506
[TBL] [Abstract][Full Text] [Related]
24. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
[TBL] [Abstract][Full Text] [Related]
25. The anti-secretory and anti-ulcer activities of esomeprazole in comparison with omeprazole in the stomach of rats and rabbits.
Bastaki SM; Chandranath IS; Singh J
Mol Cell Biochem; 2008 Feb; 309(1-2):167-75. PubMed ID: 18044010
[TBL] [Abstract][Full Text] [Related]
26. Indomethacin-induced morphological changes in the rat gastric mucosa, with or without prior treatment with two proton pump inhibitors.
Morini G; Grandi D; Arcari ML; Bertaccini G
Aliment Pharmacol Ther; 1995 Dec; 9(6):615-23. PubMed ID: 8824648
[TBL] [Abstract][Full Text] [Related]
27. Effect of omeprazole on gastric acid secretion by the rat isolated stomach.
Coruzzi G; Adami M; Moretti U; Bertaccini G
Pharmacol Res Commun; 1986 Mar; 18(3):257-71. PubMed ID: 2873595
[TBL] [Abstract][Full Text] [Related]
28. Proton-pump inhibition for acid-related disease.
Holt S
South Med J; 1991 Sep; 84(9):1078-87. PubMed ID: 1653998
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress.
Otani Y; Kitajima M; Sugiyama M; Watanabe Y; Aoki T
J Clin Gastroenterol; 1995; 20 Suppl 2():S22-6. PubMed ID: 7594333
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the gastroprotective activity of cordatin, a diterpene isolated from Aparisthmium cordatum (Euphorbiaceae).
Hiruma-Lima CA; Gracioso JD; Toma W; de Paula AC; de Almeida AB; Brasil DD; Muller AH; Brito AR
Biol Pharm Bull; 2000 Dec; 23(12):1465-9. PubMed ID: 11145179
[TBL] [Abstract][Full Text] [Related]
32. Protection against aspirin-induced gastric lesions by lansoprazole: simultaneous evaluation of functional and morphologic responses.
Bergmann JF; Chassany O; Simoneau G; Lemaire M; Segrestaa JM; Caulin C
Clin Pharmacol Ther; 1992 Oct; 52(4):413-6. PubMed ID: 1424414
[TBL] [Abstract][Full Text] [Related]
33. Comparison of five antisecretory agents acting via gastric H+/K+-ATPase.
Bastaki SM; Chandranath I; Garner A
J Physiol Paris; 2000; 94(1):19-23. PubMed ID: 10761684
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 2-[[(4-fluoroalkoxy-2-pyridyl)methyl]sulfinyl]-1H- benzimidazoles as antiulcer agents.
Kubo K; Oda K; Kaneko T; Satoh H; Nohara A
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2853-8. PubMed ID: 2076571
[TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model.
Puchalski TA; Krzyzanski W; Blum RA; Jusko WJ
J Clin Pharmacol; 2001 Mar; 41(3):251-8. PubMed ID: 11269565
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
37. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.
Bruley des Varannes S; Levy P; Lartigue S; Dellatolas F; Lemaire M; Galmiche JP
Aliment Pharmacol Ther; 1994 Jun; 8(3):309-14. PubMed ID: 7918926
[TBL] [Abstract][Full Text] [Related]
38. [Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].
Murakami I; Asano S; Yukishige K; Nagaya H; Satoh H; Inatomi N
Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):323-32. PubMed ID: 9017686
[TBL] [Abstract][Full Text] [Related]
39. Gastric acid secretion: activation and inhibition.
Sachs G; Prinz C; Loo D; Bamberg K; Besancon M; Shin JM
Yale J Biol Med; 1994; 67(3-4):81-95. PubMed ID: 7502535
[TBL] [Abstract][Full Text] [Related]
40. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
Blum RA
Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
